Literature DB >> 12458047

Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes.

Chang Jiang Guo1, Jian Ping Lai, Hong Mei Luo, Steven D Douglas, Wen Zhe Ho.   

Abstract

Substance P (SP) is an important modulator of neuroimmunoregulation. We have demonstrated that human T lymphocytes express SP and neurokinin-1 receptor (NK-1R), a primary SP receptor. In the present study, we investigated whether SP stimulates synthesis of macrophage inflammatory protein-1beta (MIP-1beta) in human T lymphocytes. SP significantly enhanced MIP-1beta expression at both the mRNA and protein level in a human T cell line (Jurkat) containing the SP receptor gene (J-SPR) as determined by real-time PCR and ELISA assays. SP-induced MIP-1beta expression is abrogated by the specific NK-1R antagonist (CP-96,345). The supernatants from SP-stimulated J-SPR T cell cultures enhanced T lymphocyte chemotaxis in vitro, indicating functional activity of SP-induced MIP-1beta. In addition, SP augmented secretion of MIP-1beta from primary cultures of peripheral blood lymphocytes (PBL) isolated from some of the donors. This donor variability was due to differential expression of the primary SP receptor (NK-1R) on PBL from different donors. PBL from two of seven donors that did not respond to SP stimulation had undetectable NK-1R expression. Our mechanistic studies showed that SP activated NF-kappaB promoter-directed luciferase activity, which may be responsible for its effect on MIP-1beta expression in human T cells. Our data provide a potential mechanism by which SP selectively influences cellular immune responses such as beta-chemokine expression in human T lymphocytes through NK-1R, which may have an important in vivo implication in inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458047      PMCID: PMC4009682          DOI: 10.1016/s0165-5728(02)00277-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  34 in total

1.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells.

Authors:  S Dunzendorfer; A Kaser; C Meierhofer; H Tilg; C J Wiedermann
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

3.  Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells.

Authors:  I Marriott; M J Mason; A Elhofy; K L Bost
Journal:  J Neuroimmunol       Date:  2000-01-24       Impact factor: 3.478

4.  HIV enhances substance P expression in human immune cells.

Authors:  Wen-Zhe Ho; Jian-Ping Lai; Yuan Li; Steven D Douglas
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

5.  Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells.

Authors:  M T Tran; R N Lausch; J E Oakes
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-11       Impact factor: 4.799

6.  Human stem cells express substance P gene and its receptor.

Authors:  Y Li; S D Douglas; W Ho
Journal:  J Hematother Stem Cell Res       Date:  2000-08

7.  Detection of substance P and its receptor in human fetal microglia.

Authors:  J P Lai; G X Zhan; D E Campbell; S D Douglas; W Z Ho
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

8.  Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB.

Authors:  R Rezzonico; V Imbert; R Chicheportiche; J M Dayer
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

9.  Substance P receptor-mediated chemotaxis of human monocytes.

Authors:  M R Ruff; S M Wahl; C B Pert
Journal:  Peptides       Date:  1985       Impact factor: 3.750

10.  Human lymphocytes express substance P and its receptor.

Authors:  J P Lai; S D Douglas; W Z Ho
Journal:  J Neuroimmunol       Date:  1998-06-01       Impact factor: 3.478

View more
  17 in total

Review 1.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

2.  Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.

Authors:  J-P Lai; W Z Ho; L E Kilpatrick; X Wang; F Tuluc; H M Korchak; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-04       Impact factor: 11.205

3.  Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor.

Authors:  Linda Monaco-Shawver; Lynnae Schwartz; Florin Tuluc; Chang-Jiang Guo; Jian Ping Lai; Satya M Gunnam; Laurie E Kilpatrick; Pinaki P Banerjee; Steven D Douglas; Jordan S Orange
Journal:  J Leukoc Biol       Date:  2010-10-12       Impact factor: 4.962

4.  Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil kinase-dependent mechanism.

Authors:  John Meshki; Steven D Douglas; Jian-Ping Lai; Lynnae Schwartz; Laurie E Kilpatrick; Florin Tuluc
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

5.  An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P.

Authors:  Xu Wang; Steven D Douglas; Jin-Song Peng; Dun-Jin Zhou; Qi Wan; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

6.  Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.

Authors:  Chang-Jiang Guo; Steven D Douglas; Zhiyong Gao; Bryan A Wolf; Judith Grinspan; Jian-Ping Lai; Eric Riedel; Wen-Zhe Ho
Journal:  Glia       Date:  2004-11-15       Impact factor: 7.452

7.  Substance P regulates macrophage inflammatory protein 3alpha/chemokine C-C ligand 20 (CCL20) with heme oxygenase-1 in human periodontal ligament cells.

Authors:  S-K Lee; S-H Pi; S-H Kim; K-S Min; H-J Lee; H-S Chang; K-H Kang; H-R Kim; H-I Shin; S-K Lee; E-C Kim
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

8.  Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.

Authors:  Sergei Spitsin; Florin Tuluc; John Meshki; Jian Ping Lai; Richard Tustin Iii; Steven D Douglas
Journal:  Neuroimmunomodulation       Date:  2013-07-05       Impact factor: 2.492

9.  Role of NOS2 in pulmonary injury and repair in response to bleomycin.

Authors:  Changjiang Guo; Elena Atochina-Vasserman; Helen Abramova; Blessy George; Veleeparambil Manoj; Pamela Scott; Andrew Gow
Journal:  Free Radic Biol Med       Date:  2015-10-23       Impact factor: 7.376

10.  Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.

Authors:  M Gallicchio; E Benetti; A C Rosa; R Fantozzi
Journal:  Br J Pharmacol       Date:  2009-01-16       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.